Learn more about how Peptide Receptor Radionuclide Therapy (PRRT) can improve care for Neuroendocrine Tumor patients. Another effective illustration of how Radiotheranostics work and its application in the field of oncology.
Watch video >>
Other news & events
- News04.12.2025

#BlueNovemberWithRadiotheranostics for Urologists, Oncologists and Nuclear Medicine physicians
Read more - News10.11.2025

#BlueNovemberWithRadiotheranostics - The VISION trial: Meet Dr Alison Armour
Read more - News06.11.2025

Oncidium Foundation USA Achieves 501(c)(3) Status to Expand Patient Access to Nuclear Medicine and Theranostics
Read more




